AgeX Therapeutics, Inc.
(NYSE Amex Equities : AGE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
-0.78%45.451.4%$854.89m
JNJJohnson & Johnson
-1.13%136.960.7%$780.79m
PFEPfizer Inc.
-1.64%39.230.9%$757.00m
MRKMerck & Co., Inc.
-0.97%73.210.6%$736.55m
LLYEli Lilly and Company
-1.09%115.241.0%$721.63m
ABBVAbbVie, Inc.
-0.43%77.652.2%$381.21m
AZNAstraZeneca PLC Sponsored ADR
-0.16%38.711.3%$238.83m
NVSNovartis AG Sponsored ADR
-1.37%76.240.2%$227.15m
GSKGlaxoSmithKline plc Sponsored ADR
-0.39%39.830.2%$99.69m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.27%48.380.1%$66.68m
SNYSanofi Sponsored ADR
0.16%41.160.2%$39.51m
LCILannett Company, Inc.
2.13%7.1836.7%$7.90m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.97%3.081.6%$1.07m
EPIXESSA Pharma Inc
-9.57%2.280.1%$0.02m

Company Profile

AgeX Therapeutics, Inc. operates as a biotechnology company. It focuses on the development and commercialization of novel therapeutics targeting human aging. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.